Latus Bio Presents Data On Huntington’s Disease Gene Therapy
24 Feb 2025 //
BUSINESSWIRE
Pilatus Biosciences Secures FDA Orphan Drug Designation for PLT012
10 Dec 2024 //
PR NEWSWIRE
Latus Launches With $54M Series A, Gene Therapy Tech, Candidates
02 May 2024 //
BUSINESSWIRE